Real-World Evidence for Assessing Treatment Effectiveness and Safety in Pediatric Populations.
作者信息
Horton Daniel B, Blum Michael D, Burcu Mehmet
机构信息
Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ; Rutgers Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, New Brunswick, NJ; Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, NJ.
Office of Pharmacovigilance and Epidemiology, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
出版信息
J Pediatr. 2021 Nov;238:312-316. doi: 10.1016/j.jpeds.2021.06.062. Epub 2021 Jul 2.
Abstract
摘要
相似文献
1
Real-World Evidence for Assessing Treatment Effectiveness and Safety in Pediatric Populations.评估儿科人群治疗有效性和安全性的真实世界证据。
J Pediatr. 2021 Nov;238:312-316. doi: 10.1016/j.jpeds.2021.06.062. Epub 2021 Jul 2.
2
Establishing CASA as an evidence-based practice.将CASA确立为基于证据的实践。
J Evid Based Soc Work. 2013;10(4):321-37. doi: 10.1080/15433714.2012.663674.
3
Nonrandomized Real-World Evidence to Support Regulatory Decision Making: Process for a Randomized Trial Replication Project.支持监管决策的非随机真实世界证据：随机试验复制项目的流程。
Clin Pharmacol Ther. 2020 Apr;107(4):817-826. doi: 10.1002/cpt.1633. Epub 2019 Oct 25.
4
[When the information provided to participants of a comparative effectiveness trial ends up in the court: The opening of Pandora's box?].当提供给比较效果试验参与者的信息最终进入法庭时：潘多拉魔盒被打开了？
Med Clin (Barc). 2016 Jul 15;147(2):76-80. doi: 10.1016/j.medcli.2016.01.008. Epub 2016 Mar 6.
5
Real-World Evidence and Real-World Data for Evaluating Drug Safety and Effectiveness.用于评估药物安全性和有效性的真实世界证据与真实世界数据。
JAMA. 2018 Sep 4;320(9):867-868. doi: 10.1001/jama.2018.10136.
6
Using Electronic Medical Records to Assess the Effectiveness of Pharmacotherapy in Pain: A Review of Recent Observational Studies.利用电子病历评估药物治疗疼痛的有效性：近期观察性研究综述
J Pain Palliat Care Pharmacother. 2016 Sep;30(3):210-7. doi: 10.1080/15360288.2016.1184215. Epub 2016 Jun 3.
7
Using Real-World Data to Extrapolate Evidence From Randomized Controlled Trials.利用真实世界数据从随机对照试验中推断证据。
Clin Pharmacol Ther. 2019 May;105(5):1156-1163. doi: 10.1002/cpt.1210. Epub 2018 Sep 24.
8
Who are we missing? Underrepresentation of data sources used for pharmacoepidemiology research in the United States.我们遗漏了谁？美国药物流行病学研究中数据源代表性不足。
Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1494-1498. doi: 10.1002/pds.5087. Epub 2020 Aug 20.
9
10
Regulatory considerations on the enrollment of older adults in oncology clinical trials.肿瘤学临床试验中老年受试者入组的监管考量
J Geriatr Oncol. 2017 May;8(3):151-153. doi: 10.1016/j.jgo.2017.02.006. Epub 2017 Mar 9.
引用本文的文献
1
Overcoming the blood-brain barrier (BBB) in pediatric CNS tumors: immunotherapy and nanomedicine-driven strategies.克服小儿中枢神经系统肿瘤中的血脑屏障：免疫疗法和纳米医学驱动策略
Med Oncol. 2025 Aug 19;42(10):431. doi: 10.1007/s12032-025-02984-y.
2
Data Missingness and Equity Implications in the Nation's Largest Student Fitness Surveillance System: The New York City School Based Physical Fitness Testing Programs, 2006-2020.美国最大的学生体能监测系统中的数据缺失情况及公平性影响：纽约市学校体育体能测试项目，2006 - 2020年
J Sch Health. 2025 Jul;95(7):498-509. doi: 10.1111/josh.70021. Epub 2025 May 19.
3
Drug Development in Pediatric Chronic Kidney Disease: A Review of Promising Treatments, Old Challenges, and New Strategies.儿童慢性肾脏病的药物研发：对有前景的治疗方法、旧挑战及新策略的综述
Paediatr Drugs. 2025 May;27(3):283-291. doi: 10.1007/s40272-025-00684-8. Epub 2025 Feb 10.
4
Validation of new medication use algorithms as proxies for worsening disease activity in patients with juvenile idiopathic arthritis.验证新的药物使用算法作为青少年特发性关节炎患者疾病活动恶化的替代指标。
Pharmacoepidemiol Drug Saf. 2024 May;33(5):e5803. doi: 10.1002/pds.5803.
5
Pediatric oncology drug development and dosage optimization.儿科肿瘤学药物研发与剂量优化
Front Oncol. 2024 Jan 29;13:1235947. doi: 10.3389/fonc.2023.1235947. eCollection 2023.
6
Creating a Medication Therapy Observational Research Database from an Electronic Medical Record: Challenges and Data Curation.从电子病历中创建药物治疗观察研究数据库：挑战与数据管理。
Appl Clin Inform. 2024 Jan;15(1):111-118. doi: 10.1055/s-0043-1777741. Epub 2024 Feb 7.
8
Overview of global real-world data sources for pediatric pharmacoepidemiologic research.儿科药物流行病学研究全球真实世界数据源概述。
Pharmacoepidemiol Drug Saf. 2024 Jan;33(1):e5695. doi: 10.1002/pds.5695. Epub 2023 Sep 10.
9
Landscape analysis for a neonatal disease progression model of bronchopulmonary dysplasia: Leveraging clinical trial experience and real-world data.支气管肺发育不良新生儿疾病进展模型的景观分析：利用临床试验经验和真实世界数据
Front Pharmacol. 2022 Oct 12;13:988974. doi: 10.3389/fphar.2022.988974. eCollection 2022.
10
An Innovative Approach to Building an Effective and Efficient Pediatric Trial Network.构建高效儿科试验网络的创新方法。
Hosp Pediatr. 2022 Sep 1;12(9):e309-e311. doi: 10.1542/hpeds.2022-006811.
Zotero 插件